Drug Search Results
Using advanced filters...
Advanced Search [+]

dexrabeprazole

Alternative Names: dexrabeprazole
Latest Update: 2023-09-10
Latest Update Note: News Article

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Dominican Republic | India | Lebanon | Turkey

Approved Indications: None

Known Adverse Events: None

Company: Jiangsu Aosaikang
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for dexrabeprazole

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Duodenal Ulcer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20170066

P3

Recruiting

Duodenal Ulcer

None

Recent News Events